Analysis of promoter methylation of Dickkopf1 (DKK1) gene in breast cancer
dc.contributor.author | Acar, Muradiye | |
dc.contributor.author | Cora, Tulin | |
dc.contributor.author | Toy, Hatice | |
dc.contributor.author | Acar, Hasan | |
dc.date.accessioned | 2020-03-26T18:23:51Z | |
dc.date.available | 2020-03-26T18:23:51Z | |
dc.date.issued | 2012 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | Aim: Breast cancer is the most common malignancy in women worldwide. The Dickkopf1 (DKK1) gene product is a potent inhibitor of the Wnt pathway. DKK1 methylation status and its protein expression were examined in normal and cancer tissues of breast cancer patients. Materials and methods: We examined methylation changes in 83 tumor and adjacent normal tissues, and also in 9 normal breast tissues from unaffected women (no breast cancer history) as controls. DKK1 promoter methylation was assessed by methylation-specific polymerase chain reaction. Immunohistochemical staining was used to investigate DKK1 protein expression in the 9 controls and in 70 out of the 83 tumors as well as their adjacent normal tissues. Immunohistochemical results were categorized as positive or negative for DKK1. Results: DKK1 gene methylation was detected in 3 out of the 9 (33%) normal breast tissue samples of unaffected women. The DKK1 gene was hypermethylated in 58 out of the 83 (70%) tumor samples and 51 out of the 83 (61%) adjacent normal tissue samples. In immunohistochemistry, 33% of normal breast tissue from unaffected women, 31% of the tumors, and 17% of the adjacent normal tissues in the breast cancer patients were found to be DKK1-positive. DKK1 promoter methylation and protein expression were not associated with age, tumor size, lymph node status, histological grade, estrogen/progesterone receptor status, or HER2 positivity. Conclusion: Our results indicate that there is a concordant DKK1 methylation change between normal and cancerous breast tissue. | en_US |
dc.identifier.doi | 10.3906/sag-1204-30 | en_US |
dc.identifier.endpage | 1387 | en_US |
dc.identifier.issn | 1300-0144 | en_US |
dc.identifier.issn | 1303-6165 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 1379 | en_US |
dc.identifier.uri | https://dx.doi.org/10.3906/sag-1204-30 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/27740 | |
dc.identifier.volume | 42 | en_US |
dc.identifier.wos | WOS:000321226500004 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | TUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL TURKEY | en_US |
dc.relation.ispartof | TURKISH JOURNAL OF MEDICAL SCIENCES | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | Breast cancer | en_US |
dc.subject | Dickkopf1 | en_US |
dc.subject | DNA methylation | en_US |
dc.title | Analysis of promoter methylation of Dickkopf1 (DKK1) gene in breast cancer | en_US |
dc.type | Article | en_US |